PCSK9抑制剂Evolocumab和Alirocumab降低血脂和减少心血管事件的有效性和安全性评价
Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events
PCSK9抑制剂Evolocumab和Alirocumab降低血脂和减少心血管事件的有效性和安全性评价 |
| 评价者:刘金来, 文献合成者:李苏华 |
Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events |
| |